Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data

BACKGROUND: Coronavirus disease in 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic. Published data suggests that patients with a history of or active malignancy are at increased risk of infection and developing COVID-19 related...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabezón-Gutiérrez, Luis, Custodio-Cabello, Sara, Palka-Kotlowska, Magda, Oliveros-Acebes, Eduardo, García-Navarro, María José, Khosravi-Shahi, Parham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Hot Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462449/
https://www.ncbi.nlm.nih.gov/pubmed/32947121
http://dx.doi.org/10.1016/j.ctrv.2020.102102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462449/
https://www.ncbi.nlm.nih.gov/pubmed/32947121
http://dx.doi.org/10.1016/j.ctrv.2020.102102

Ejemplares similares